鲁比前列酮对与长期糖尿病性黄斑水肿相关的视力下降的影响。 - Suppr | 超能文献

Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.

作者信息

Sahu Atul Kumar, Majji Ajit Babu

出版信息

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6890; author reply 6890-1. doi: 10.1167/iovs.09-4106.

DOI:10.1167/iovs.09-4106

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.鲁比前列酮对与长期糖尿病性黄斑水肿相关的视力下降的影响。

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6890; author reply 6890-1. doi: 10.1167/iovs.09-4106.

2

Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.鲁比前列酮对与长期糖尿病性黄斑水肿相关的视力下降的影响。

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):1-4. doi: 10.1167/iovs.08-2473. Epub 2008 Aug 15.

3

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.鲁比前列酮对糖尿病视网膜病变患者视力丧失的影响。

Ophthalmology. 2006 Dec;113(12):2221-30. doi: 10.1016/j.ophtha.2006.07.032. Epub 2006 Sep 20.

4

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.口服蛋白激酶 Cβ抑制剂罗格列酮在两项 3 期研究中对视力丧失的影响。

Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1750-7. doi: 10.1167/iovs.12-11055.

5

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.口服蛋白激酶 Cβ 抑制剂罗格列酮治疗糖尿病视网膜病变：蛋白激酶 Cβ 抑制剂-糖尿病视网膜病变研究和蛋白激酶 Cβ 抑制剂-糖尿病视网膜病变研究 2 中 813 例（1392 只眼）糖尿病视网膜病变患者的疗效、安全性和视力丧失的原因。

Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669.

6

Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).罗格列酮（RBX）对停药和重新开始治疗 6 年内视力下降的影响：蛋白激酶 C 糖尿病视网膜病变研究 2（PKC-DRS2）开放标签扩展的结果。

Retina. 2011 Jun;31(6):1053-9. doi: 10.1097/IAE.0b013e3181fe545f.

7

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.鲁比前列酮对糖尿病性黄斑水肿患者的影响：PKC-DMES随机临床试验的30个月结果

Arch Ophthalmol. 2007 Mar;125(3):318-24. doi: 10.1001/archopht.125.3.318.

8

Diabetic macular oedema and visual loss: relationship to location, severity and duration.糖尿病性黄斑水肿与视力丧失：与位置、严重程度和持续时间的关系。

Acta Ophthalmol. 2009 Nov;87(7):709-13. doi: 10.1111/j.1755-3768.2009.01545.x. Epub 2009 Oct 8.

9

[Medications for diabetic macular edema].[糖尿病性黄斑水肿的药物治疗]

Nihon Rinsho. 2005 Jun;63 Suppl 6:275-9.

10

Ruboxistaurin for diabetic retinopathy.鲁比前列酮用于治疗糖尿病性视网膜病变。

Ophthalmology. 2006 Dec;113(12):2135-6. doi: 10.1016/j.ophtha.2006.09.003.

引用本文的文献

1

Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.糖尿病视网膜病变 Ins2(Akita)小鼠模型中的视网膜血管生成。

Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):574-84. doi: 10.1167/iovs.12-10959.